EMA Withdrawn: Nevirapine Teva (nevirapine) — Teva B.V.

View source ↗

Summary

EMA withdrew Nevirapine Teva (nevirapine) from the market; HIV infections was the therapeutic area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Nevirapine Teva (nevirapine)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Teva B.V.. Decision date: 08/12/2021